CBD in pharmacies
In 2025, CBD in pharmacies generates as much interest as questions, and for good reason: between strict legislation, concrete medical benefits, and a growing market, cannabidiol has become a true player in wellness and care. Whether you are curious, a patient seeking natural solutions, or simply looking for reliable information on the current uses of CBD — this article updates all important data as of July 2025, with examples, key figures, and answers to frequently asked questions.
French legislation on CBD in pharmacies in 2025
If you're wondering whether CBD sold in pharmacies is actually legal in France, the answer is yes — but under certain conditions. According to the updated guide from Origine CBD, products must contain less than 0.3% THC and come from expressly authorized hemp varieties.
Pharmacists must guarantee full traceability and sell only compliant products: full-spectrum oils, certified flowers, or standardized capsules.
Reinforced controls imposed by the AFMPS and European authorities ensure that what you find in pharmacies today adheres to rigorous protocols.
To learn more about these regulatory and legal obligations still in force this week: Click here.
Problems that CBD concretely relieves in pharmacies
- Refractory neuropathic pain: often linked to multiple sclerosis, this chronic pain has found significant relief thanks to CBD.
- Muscle spasticity: patients with neurological conditions report improvements without heavy side effects.
- Supportive care in oncology: used in palliative care or to alleviate adverse effects of anti-cancer treatments.
- Safety of use: pharmaceutical CBD products meet a growing demand for natural but medically supervised solutions.
According to the Barong CBD article published on July 11, 2025, all these pathologies are already covered by the national experiment supervised by the French State for more than three years.
Benefits reported by French users
- Relaxation & anti-stress: this is one of the primary effects felt by the majority of consumers.
- Targeted pain reduction: significant results on certain pains resistant to usual treatments according to patient feedback from the national experiment.
- Purchase safety: access via pharmacies strengthens confidence in this type of natural product that complies with French and European standards.
Want to know what the best offers are this month? Consult our updated summary article: Cheap CBD in July.
Concrete examples in France: recent use cases (2025)
The large-scale concrete experiment conducted since March 2021 already involves more than 3,000 French patients treated in a strictly medical setting. The areas covered?
- Chronic neuropathic pain (diabetes, MS, etc.)
- Neurological spasticity (including amyotrophic lateral sclerosis)
- Epilepsies resistant to traditional medications
- Advanced palliative care (metastatic cancers in particular)
All these cases are currently benefiting from positive field feedback via the national protocol still active at the end of July 2025.
Key figures for the updated French CBD market
| Indicator | Value (2025) |
|---|---|
| French CBD market size | €600 million (projected) |
| Penetration rate in France | 71% aware / +6 million consumed |
| Young adult segment (18–34 years) | 17.5% usage rate observed |
| Average annual growth | +50% between end 2022 and end 2023 Continued growth expected until 2026 |
Current FAQ on CBD accessible in pharmacies (July 2025)
- What products can I buy? : Sublingual full-spectrum oils compatible with pharmacies; packaged flowers with full traceability.
Find more answers in our complete collection: 👉 CBD FAQ – July edition
Finding CBD in pharmacies has become an increasingly common practice in France. In July 2025, consumers are primarily looking for safe, legal, and suitable products for daily consumption. They want to understand new regulations, find practical formats for microdosing, and receive personalized advice. In this article, based on the most current search trends, we explore in depth what French people truly expect when they turn to their pharmacy to buy CBD.
The most frequently asked questions about CBD in pharmacies
This month, several questions come up repeatedly:
- What is the current regulation concerning CBD sold in pharmacies?
- Which products are suitable for microdosing (mild oils, capsules, gummies)?
- How to choose a premium product? How important are origin and extraction?
- What innovations are available in pharmacies this year: functional infusions, sprays...?
- Is CBD more controlled in pharmacies than in specialized stores?
Also read: CBD: what European law says
The main problems consumers want to solve
CBD sold in pharmacies is positioned as a natural answer to a large number of ailments:
- Insomnia and mild or fragmented sleep disorders
- Chronic stress and non-pathological daily anxiety
- Muscle pain or tension after physical activity
- Desire to reduce the use of chemical drugs such as benzodiazepines or sleeping pills
- Search for constant well-being without noticeable side effects
After their research, what do consumers do?
Once they have found concrete answers, many take action:
- They buy CBD directly from pharmacies to benefit from the advice of a healthcare professional
- They experiment with progressive microdosing to observe their reaction to the product
- They favor local certified organic products with eco-responsible packaging
- They subscribe to pharmacies that offer personalized monthly formulas
- They share their feedback on Reddit or in specialized Facebook groups
Frequent objections and persistent fears
Despite the normalization of CBD in France, certain concerns regularly arise:
- The question of the legal THC level (0.3% max) remains a source of doubt
- Some question the traceability and actual quality of products sold
- The efficacy declared by brands does not always match actual results for all individuals
- Users are concerned about interactions with medical treatments or psychiatric history
- Confusion between recreational cannabis and legal CBD still persists among some of the population
Good to know: Pharmacies offering CBD products that comply with French standards are more reassuring than some exotic or vague online stores.
Who are today's users? Typical profile in July 2025
The typical profile has evolved significantly in recent years:
- Mostly beginners or intermediates: they seek guidance to better understand what they are consuming.
- Some advanced profiles: those passionate about plant chemistry or very informed about cannabinoids represent a minority.
- Seniors are progressing: well supervised by their pharmacist or treating physician, they are timidly adopting oil under the tongue.
Associated searches and related topics seeing strong growth this month
- Microdosed CBD drinks (infused mineral water)
- Relaxing organic hemp infusions for light sleep without dependency
- Demystification of daily microdosing via low-dose oils and capsules (less than 5mg CBD per dose)
- Strict French regulation revised mid-2025 with reinforced control over authorized residual THC
- Comparison with the future of French therapeutic cannabis (see current trends)
New concerns emerging since last April:
- Recent reinforcement around the maximum THC level required in all legally sold items, including those without mandatory medical prescription.
- Marked sensitivity around products with verifiable blockchain traceability or public laboratory analysis.
- Strong emphasis on eco-designed packaging and French eco-responsible markers (officially certified labels)
- Frequent topics around possible associations between cannabidiol and heavy treatments in fragile patients (seniors in particular)
- Better explanation of the distinction between illegal euphoric substances like THC versus legally usable CBD molecules without cognitive alteration.
Leave a comment